TY - JOUR AU - Song, Tingting AU - Fu, Yang AU - Wang, Yanbo AU - Li, Wei AU - Zhao, Jiayu AU - Wang, Xun AU - Wang, Haiyan AU - Zhao, Ying AU - Fu, Xianghua PY - 2021 DA - 2021/01/07 TI - FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI JO - BMC Cardiovascular Disorders SP - 24 VL - 21 IS - 1 AB - The present study aimed to assess the correlation of fibroblast growth factor (FGF)-23 expression with clinical characteristics, then further explore its value in predicting 2-year in-stent restenosis (ISR) risk in coronary heart disease (CHD) patients underwent percutaneous coronary intervention (PCI) with drug-eluting stent (DES). SN - 1471-2261 UR - https://doi.org/10.1186/s12872-020-01839-w DO - 10.1186/s12872-020-01839-w ID - Song2021 ER -